Atopic Dermatitis Market Size, Share, Development, Growth and Demand Forecast 2020 to 2027
Verfasser: ashwani_kailiya on Thursday, 11 June 2020Global atopic dermatitis market is poised for astounding growth at approximately 24.1% CAGR during the projection period (2020-2027). Millions of people continue to be affected by debilitating skin ailments which in turn escalates the development of new pharmaceutical drugs. Fact.MR projects the revenue of atopic dermatitis market to exceed US$ 19 Bn by 2027 end.
“Growing prevalence of dermatological disorders is contributing to the growth of atopic dermatitis market. Manufacturers across the globe are expediting the research and development of novel pipeline drugs. Convenience, affordability, and availability of therapeutic drugs are ascribed for robust market growth,” concludes Fact.MR.
Request for Sample detailed COVID-19 impact analysis on the Market @ https://www.factmr.com/connectus/sample?flag=S&rep_id=4603
Atopic Dermatitis Market – Key Findings
PDE4 inhibitors and biologics drugs account for leading share in atopic dermatitis market.
Retail pharmacies will remain the prominent distribution channel over the projection period.
North America atopic dermatitis market will maintain its regional hegemony through 2027.
Europe will account for 1/3rd of revenue share in the global atopic dermatitis market.
Atopic Dermatitis Market – Key Driving Factors